Story thread · 2 reports / 2 sources
Roche, Dualitas team up to find bispecific drugs for immune diseases
biopharmadive.com · 2h · first report
Through a research deal worth up to $1 billion, Dualitas will sift through more than 300,000 possible bispecific combinations in the hopes of unearthing new and differentiating treatments.
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.